| Today, Mon, Nov 30, 2009 | | • | Human Genome Sciences to sell up to 12.5M shares
AP (Mon 5:01pm)
| | • | Making Money More Efficiently
at Motley Fool (Mon 3:25pm)
| | • | Anxious No Longer
at Motley Fool (Mon 2:44pm)
| | • | Van Berkom And Associates Prices Health Care And Industrial Companies
Wall Street Transcript (Mon 1:37pm)
| | • | The Real Problem With the Public Health-Care Plan
at Motley Fool (Mon 12:49pm)
| | • | China Biotech Week in Review: Two More R&D Centers, One PE Fund, One IPO
at Seeking Alpha (Mon 7:33am)
| | Sat, Nov 28, 2009 | | • | Increase In Patent Protection For Biologics Creates Significant Upside For Drug Development Enterprise Valuations
Wall Street Transcript (Sat, Nov 28)
| | • | The Dow Should Be at 250,000
at Motley Fool (Sat, Nov 28)
| | Fri, Nov 27, 2009 | | • | Biotech Bargains for Your Portfolio
at Motley Fool (Fri, Nov 27)
| | • | 7 of the Most Efficient Companies on the Planet
at Motley Fool (Fri, Nov 27)
| | • | 3 China Profit Plays
at Motley Fool (Fri, Nov 27)
| | Thu, Nov 26, 2009 | | • | Theravance, Inc.: Wait to Buy on Dip
at Seeking Alpha (Thu, Nov 26)
| | Wed, Nov 25, 2009 | | • | A Schizophrenic Move by Merck?
at Motley Fool (Wed, Nov 25)
| | • | Human Genome Begins Trial
Zacks.com (Wed, Nov 25)
| | Tue, Nov 24, 2009 | | • | [video] Topping the Tape
at CNBC (Tue, Nov 24)
| | • | How Big Pharma Profits from Swine Flu
at BusinessWeek (Tue, Nov 24)
| | • | Batch of swine flu vaccines studied in Canada
AP (Tue, Nov 24)
| | • | GlaxoSmithKline pulls swine flu vaccines in Canada
AP (Tue, Nov 24)
| | • | Gilead signs sales deal with Glaxo for Viread
AP (Tue, Nov 24)
| | • | Wall to Wall Street Coverage: Upgrades and Downgrades
Minyanville (Tue, Nov 24)
|
Add GSK News to My Yahoo!:
 
| |
|
0.34% Nasdaq 
0.79 (1.87%) 
Headlines
